These immunotherapy technologies are very interest
Post# of 36537
(Total Views: 206)
Posted On: 06/25/2019 10:28:26 AM
These immunotherapy technologies are very interesting. Initially, they will probably be used for people who are very ill, considering the potential side effects. I'm not sure how AE37 fits into this spectrum of treatments. However, the recent "Right to Try" legislation may be a boon to immunotherapy applications for cancer.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼